Kainos Medicine, Inc. (KOSDAQ:284620)

Kainos Medicine Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	672.92	2,866	3,834	16,337	24,952	23,231
Short-Term Investments	100	-	-	79.85	5,000	11,000
Cash & Short-Term Investments	772.92	2,866	3,834	16,417	29,952	34,231
Cash Growth	-83.57%	-25.24%	-76.64%	-45.19%	-12.50%	14.82%
Accounts Receivable	355.57	255.33	252.77	83.75	-0	0
Other Receivables	39.33	36.26	62.53	4.35	295.7	290.89
Receivables	394.9	291.58	490.3	88.1	295.7	290.89
Prepaid Expenses	92	157.88	96.69	258.68	949.3	2,020
Other Current Assets	1,006	1,094	182.94	353.43	38.45	331.12
Total Current Assets	2,266	4,410	4,604	17,117	31,236	36,873
Property, Plant & Equipment	38.22	-	602.75	875.47	5,437	3,334
Long-Term Investments	1,574	2,138	3,503	786.56	740.63	642.79
Other Intangible Assets	40.4	-	501.61	810.67	861.84	689.04
Long-Term Accounts Receivable	-	-	-0	0	-0	-0
Other Long-Term Assets	241.42	70.15	1,531	1,395	707.04	418.79
Total Assets	4,159	6,617	10,742	20,985	38,982	41,957

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	305.61	256.38	99.83	49.92	65.04	575.51
Short-Term Debt	-	-	-	-	761.67	12,468
Current Portion of Long-Term Debt	-	-	-	-	2,285	-
Current Portion of Leases	31.25	147.28	355.37	352.17	550.74	276.27
Other Current Liabilities	1,628	1,611	1,931	1,400	1,213	8,779
Total Current Liabilities	1,965	2,014	2,386	1,802	4,876	22,099
Long-Term Debt	-	-	-	-	-	1,523
Long-Term Leases	-	-	135.91	48.66	314.34	103.95
Other Long-Term Liabilities	-	-	33.75	36.62	73.8	73.92
Total Liabilities	1,965	2,014	2,556	1,888	5,264	23,800

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	16,543	16,543	14,090	13,961	13,961	11,029
Additional Paid-In Capital	116,111	116,022	111,617	110,117	110,117	84,564
Retained Earnings	-139,021	-136,389	-128,605	-116,414	-101,179	-85,298
Treasury Stock	-40.95	-40.95	-40.95	-55.12	-55.12	-22.72
Comprehensive Income & Other	5,145	5,012	4,726	4,143	3,266	1,831
Total Common Equity	-1,262	1,147	1,788	11,751	26,109	12,104
Minority Interest	3,456	3,456	4,086	4,020	3,808	2,497
Shareholders' Equity	2,194	4,603	8,186	19,098	33,719	18,157
Total Liabilities & Equity	4,159	6,617	10,742	20,985	38,982	41,957

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	31.25	147.28	491.29	400.83	3,912	14,372
Net Cash (Debt)	741.66	2,719	3,343	16,016	26,040	19,859
Net Cash Growth	-83.15%	-18.66%	-79.13%	-38.50%	31.12%	7.24%
Net Cash Per Share	22.58	85.95	120.11	573.59	1092.41	937.14
Filing Date Shares Outstanding	33.09	32.71	27.81	27.92	27.92	22.06
Total Common Shares Outstanding	33.09	32.71	27.81	27.92	27.92	22.06
Working Capital	300.37	2,395	2,218	15,315	26,360	14,774
Book Value Per Share	-38.13	35.06	64.30	420.94	935.25	548.77
Tangible Book Value	-1,302	1,147	1,286	10,941	25,247	11,414
Tangible Book Value Per Share	-39.35	35.06	46.26	391.90	904.38	517.53
Machinery	-	-	743.51	760.19	749.6	725.66
Construction In Progress	-	-	-	-	3,829	2,287

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error